Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.4.21.64 (proteinase K)
 4,071 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The rat hepatic S14 gene is regulated by L-triiodothyronine (T3) and codes for a cytosolic protein (pI 4.9 and Mr 17,010) that is believed to be involved in lipogenesis. Recent studies have identified at least five DNase I hypersensitive sites (HS 1-5) in hepatic chromatin flanking the 5' region of the gene. The HS-1 site is situated immediately adjacent to the transcription initiation site. We have isolated a DNA fragment (USS-1) which contains a portion of the HS-1 site to examine the binding of nuclear proteins to S14 DNA. DNase I footprinting studies demonstrated that material extracted from hepatic nuclei with 0.42 M NaCl contained proteinase K-sensitive factors (presumed to be proteins), which bind to USS-1 DNA between positions -63 and -48 (PS-1) relative to the transcription initiation site. Examination of the binding activity with a synthetic oligonucleotide identical to the protected sequence indicated the formation of at least three protein-DNA complexes. The DNA binding activity of the PS-1 binding protein or proteins correlated with the T3 regulated expression of mRNA-S14. Although the nucleotide sequence of PS-1 closely resembles the binding site for the CCAAT transcription factor (CTF/NF-1), competition studies attempting to displace protein binding from the PS-1 sequence with DNA fragments containing the CTF/NF-1 binding motif were unsuccessful. In vitro transcriptional assay studies suggested that the DNA fragment (-441 to -2) containing the PS-1 site promotes the transcription of the S14 gene in an orientation fashion. The in vitro transcriptional activity of the S14 DNA containing the PS-1 sequence was significantly higher in hepatonuclear extracts from hyperthyroid compared with euthyroid or hypothyroid animals. In summary, our findings indicate that the DNA binding activity of proteins which bind to PS-1 site is influenced by the thyroid status of the animal.
 ...
PMID:Binding of nuclear proteins to the rat liver S14 gene is influenced by thyroid state. 234 5

Mitochondrial aldehyde dehydrogenase (ALDH2) activity is produced at low levels in many tissues, with highest production in liver. Transfection assays using the first 600 bp of upstream DNA provided evidence for both positive and negative regulatory elements in the proximal promoter. A region from -79 to -116 bp was protected in DNase I footprinting assays and bound in electrophoretic mobility shift assays (EMSA) by a nuclear factor found in all cell lines and tissues tested. This region, denoted FP160, contained the consensus recognition sites for Sp1 and AP2, and a CCAAT box. The CCAAT box was specifically protected by a nuclear factor in methylation interference assays. Mutagenesis of specific bp within the CCAAT box eliminated protein binding in vitro and decreased transcriptional activity from the ALDH2 promoter approximately 50% in reporter gene assays. Competition experiments showed that the nuclear factor binding to the FP160 oligodeoxyribonucleotide (oligo) was competed by oligos corresponding to an NY-Y/CP1-binding site to a greater extent than by those containing sites for CTF/NF1, C/EPB or CP2. The heat stability, resistance to proteinase K digestion, sensitivity to inhibition of DNA binding by o-phenanthroline, and immunological properties of the liver factor binding to FP160 were very similar to the corresponding properties of NF-Y/CP1. Thus, the proximal ALDH2 promoter was bound by NF-Y/CP1 and this transcription factor may be responsible for the basal expression of the gene observed in most tissues. The NFY-CP1 present in rat liver has similar properties to that previously characterized in M12 B-lymphoma cells and LMTK mouse fibroblasts.
 ...
PMID:The role of nuclear factor NF-Y/CP1 in the transcriptional regulation of the human aldehyde dehydrogenase 2-encoding gene. 896 92

The central event in the pathogenesis of prion diseases, a group of fatal, transmissible neurodegenerative disorders including Creutzfeldt-Jakob disease (CJD) in humans, is the conversion of the normal or cellular prion protein (PrPC) into the abnormal or scrapie isoform (PrPSc). The basis of the PrPC to PrPSc conversion is thought to involve the diminution of alpha-helical domains accompanied by the increase of beta structures within the PrP molecule. Consequently, treatment of PrPSc with proteinase K (PK) generates a large PK-resistant C-terminal core fragment termed PrP27-30 that in human prion diseases has a gel mobility of approximately 19-21 kDa for the unglycosylated form, and a ragged N terminus between residues 78 and 103. PrP27-30 is considered the pathogenic and infectious core of PrPSc. Here we report the identification of two novel PK-resistant, but much smaller C-terminal fragments of PrP (PrP-CTF 12/13) in brains of subjects with sporadic CJD. PrP-CTF 12/13, like PrP27-30, derive from both glycosylated as well as unglycosylated forms. The unglycosylated PrPCTF 12/13 migrate at 12 and 13 kDa and have the N terminus at residues 162/167 and 154/156, respectively. Therefore, PrP-CTF12/13 are 64-76 amino acids N-terminally shorter than PrP27-30 and are about half of the size of PrP27-30. PrP-CTF12/13 are likely to originate from a subpopulation of PrPSc distinct from that which generates PrP27-30. The finding of PrP-CTF12/13 in CJD brains widens the heterogeneity of the PK-resistant PrP fragments associated with prion diseases and may provide useful insights toward the understanding of the PrPSc structure and its formation.
 ...
PMID:Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease. 1291 18